Abbreviations CKD: Chronic kidney disease DKA: Diabetic ketoacidosis FDA: US Food and Drug Administration GLP-1 RA: Glucagon-like peptide-1 receptor agonist HCO: Healthcare organisation IHD: Ischaemic heart disease PSM: Propensity score matching SGLT2i: Sodium-glucose cotransporter 2 inhibitor SSMD: Strictly standardised mean difference UTI: Urinary tract infection References Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
Blood pressure reductions, improvements in lipid profiles (lower triglycerides, higher HDL), reductions in waist circumference, and decreases in inflammatory markers have been documented for both
Your GP can refer you to a registered dietitian for personalised nutritional advice, or to NHS weight management services for additional support with lifestyle changes alongside your Wegovy treatment
Tirzepatide has a unique dual action as it activates both GLP-1 and GIP receptors simultaneously, unlike other older drugs that only activate GLP-1 receptors (semaglutide, liraglutide, and dulaglutide)